Are 3 sentinel nodes sufficient?

被引:26
作者
Chagpar, Anees B.
Scoggins, Charles R.
Martin, Robert C. G., II
Carlson, David J.
Laidley, Alison L.
El-Eid, Souzan E.
McGlothin, Terre Q.
McMasters, Kelly M.
机构
[1] Univ Louisville, Dept Surg, Louisville, KY 40292 USA
[2] St Marys Hosp, Evansville, IN USA
[3] Deaconess Hosp, Evansville, IN USA
[4] Breast Surg N Texas, Dallas, TX USA
[5] Richardson Reg Hosp, Richardson, TX USA
[6] Hudson Valley Surg, Kingston, NY USA
关键词
D O I
10.1001/archsurg.142.5.456
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hypothesis: It has recently been proposed that only 3 sentinel lymph nodes (SLNs) are required for an adequate SLN biopsy. Others have advocated removing all nodes that are blue, hot, at the end of a blue lymphatic channel, or palpably suspicious or that have radioactive counts of 10% or greater of the most radioactive SLN. Our objective was to determine the false-negative rate (FNR) associated with limiting SLN biopsy to 3 nodes. Design: Multicenter prospective study. Setting: Both academic and private practice. Patients: A total of 4131 patients underwent SLN biopsy followed by completion axillary node dissection. Main Outcome Measure: The FNR associated with 3-node SLN biopsy. Results: Of the 4131 patients in this study, an SLN was identified in 3882 (94.0%). The median number of SLNs identified was 2; more than 3 SLNs were removed in 738 patients (17.9%). Of the patients in whom a SLN was identified, 1-358 (35.0%) were node positive. The overall FNR in this study was 7.7%. In 89.7% of node-positive patients, a positive SLN was found in the first 3 SLNs removed. If SLN biopsy had been limited to the first 3 nodes, the FNR would be 10.3% (P = .005 compared with removing >3 SLNs). The FNR increased with the strategy of limiting SLN biopsy to fewer SLNs (P < .001). Conclusion: Removing only 3 SLNs cannot be recommended, because it is associated with a substantially increased FNR.
引用
收藏
页码:456 / 459
页数:4
相关论文
共 23 条
[1]   Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer [J].
Bergkvist, L ;
Frisell, J ;
Liljegren, G ;
Celebioglu, F ;
Damm, S ;
Thörn, M .
BRITISH JOURNAL OF SURGERY, 2001, 88 (12) :1644-1648
[2]   Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer [J].
Cox, CE ;
Pendas, S ;
Cox, JM ;
Joseph, E ;
Shons, AR ;
Yeatman, T ;
Ku, NN ;
Lyman, GH ;
Berman, C ;
Haddad, F ;
Reintgen, DS .
ANNALS OF SURGERY, 1998, 227 (05) :645-653
[3]  
Dabbs David J, 2004, Breast J, V10, P186, DOI 10.1111/j.1075-122X.2004.21283.x
[4]   Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer - results of the ALMANAC validation phase [J].
Goyal, Amit ;
Newcombe, Robert G. ;
Chhabra, Alok ;
Mansel, Robert E. .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 99 (02) :203-208
[5]   Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer [J].
Gui, GPH ;
Joubert, DJ ;
Reichert, R ;
Ward, A ;
Lakhani, S ;
Osin, P ;
Nerurkar, A ;
A'Hern, R ;
Benson, K ;
Underwood, SR .
EJSO, 2005, 31 (07) :707-714
[6]   Prerandomization surgical training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial - A randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer [J].
Harlow, SP ;
Krag, DN ;
Julian, TB ;
Ashikaga, T ;
Weaver, DL ;
Feldman, SA ;
Klimberg, VS ;
Kusminsky, R ;
Moffat, FL ;
Noyes, RD ;
Beitsch, PD .
ANNALS OF SURGERY, 2005, 241 (01) :48-54
[7]   Lessons learned from 500 cases of lymphatic mapping for breast cancer [J].
Hill, ADK ;
Tran, KN ;
Akhurst, T ;
Yeung, H ;
Yeh, SDJ ;
Rosen, PP ;
Borgen, PI ;
Cody, HS .
ANNALS OF SURGERY, 1999, 229 (04) :528-535
[8]   Surgeon and community factors affecting breast cancer sentinel lymph node biopsy [J].
Hutchinson, JR ;
Chagpar, AB ;
Scoggins, CR ;
Martin, RCG ;
Carlson, DJ ;
Laidley, AL ;
El-Eid, SE ;
McGlothin, TQ ;
Noyes, RD ;
Ley, PB ;
Tuttle, TM ;
McMasters, KM .
AMERICAN JOURNAL OF SURGERY, 2005, 190 (06) :903-906
[9]   Multicentric breast cancer:: A new indication for sentinel node biopsy -: A multi-institutional validation study [J].
Knauer, Michael ;
Konstantiniuk, Peter ;
Haid, Anton ;
Wenzl, Etienne ;
Riegler-Keil, Michaela ;
Poestlberger, Sabine ;
Reitsamer, Roland ;
Schrenk, Peter .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) :3374-3380
[10]   Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial [J].
Kuehn, T ;
Vogl, FD ;
Helms, G ;
Pueckler, SV ;
Schirrmeister, H ;
Strueber, R ;
Koretz, K ;
Kreienberg, R .
EJSO, 2004, 30 (03) :252-259